Impact of Neoadjuvant Therapy on Oncological Outcomes of Patients With Distal Pancreatic Adenocarcinoma: An Intention-to-Treat Analysis

被引：0
|
作者：
Chopra, Asmita [1 ]
Khachfe, Hussein H. [2 ]
El Asmar, Rudy [2 ]
Nassour, Ibrahim [3 ]
AlMasri, Samer [4 ]
Narayanan, Sowmya [5 ]
Liu, Hao [5 ]
DeSilva, Annissa [4 ]
Singhi, Aatur [6 ]
Lee, Kenneth [7 ]
Zureikat, Amer [2 ]
Paniccia, Alessandro [7 ]
机构：
[1] Univ Toledo, Univ Pittsburgh, Toledo, OH USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
[3] Univ Florida, Dept Surg, Gainesville, FL USA
[4] Univ Pittsburgh, Med Ctr, Dept Surg Oncol, Pittsburgh, PA USA
[5] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA
[6] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[7] Univ Pittsburgh, Med Ctr, Div Surg Oncol, Pittsburgh, PA USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2023年 / 30卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E147
引用
收藏
页码：S211 / S211
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant therapy for pancreatic cancer: an intention-to-treat analysis
    Okada, Kenjiro
    Murakami, Yoshiaki
    Uemura, Kenichiro
    Kondo, Naru
    Nakagawa, Naoya
    Seo, Shingo
    Otsuka, Hiroyuki
    Takahashi, Shinya
    [J]. LANGENBECKS ARCHIVES OF SURGERY, 2020, 405 (05) : 623 - 633
  • [2] Neoadjuvant therapy for pancreatic cancer: an intention-to-treat analysis
    Kenjiro Okada
    Yoshiaki Murakami
    Kenichiro Uemura
    Naru Kondo
    Naoya Nakagawa
    Shingo Seo
    Hiroyuki Otsuka
    Shinya Takahashi
    [J]. Langenbeck's Archives of Surgery, 2020, 405 : 623 - 633
  • [3] Survival benefit of neoadjuvant therapy in patients with non-metastatic pancreatic ductal adenocarcinoma: A propensity matching and intention-to-treat analysis
    Sugimoto, Motokazu
    Takahashi, Naoki
    Farnell, Michael B.
    Smyrk, Thomas C.
    Truty, Mark J.
    Nagorney, David M.
    Smoot, Rory L.
    Chari, Suresh T.
    Carter, Rickey E.
    Kendrick, Michael L.
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (06) : 976 - 984
  • [4] Impact of care fragmentation on the outcomes of patients receiving neoadjuvant and adjuvant therapy for pancreatic adenocarcinoma
    Brown, Zachary J.
    Labiner, Hanna E.
    Shen, Chengli
    Ejaz, Aslam
    Pawlik, Timothy M.
    Cloyd, Jordan M.
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2022, 125 (02) : 185 - 193
  • [5] Impact of duration of neoadjuvant therapy on pathologic and clinical outcomes for pancreatic adenocarcinoma
    Galouzis, Nicholas
    Khawam, Maria
    Khreiss, Mohammad R.
    Mesropyan, Lusine
    Riall, Taylor S.
    Luu, Carrie
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S192 - S193
  • [6] A Bayesian sensitivity model for intention-to-treat analysis on binary outcomes with dropouts
    Kaciroti, Niko A.
    Schork, M. Anthony
    Raghunathan, Trivellore
    Julius, Stevo
    [J]. STATISTICS IN MEDICINE, 2009, 28 (04) : 572 - 585
  • [7] Neoadjuvant gemcitabine and nab-paclitaxel for borderline resectable pancreatic cancers: Intention-to-treat analysis compared with upfront surgery
    Inoue, Yosuke
    Saiura, Akio
    Oba, Atsushi
    Ono, Yoshihiro
    Mise, Yoshihiro
    Ito, Hiromichi
    Sasaki, Takashi
    Ozaka, Masato
    Sasahira, Naoki
    Takahashi, Yu
    [J]. JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2021, 28 (02) : 143 - 155
  • [8] Neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer according to intention-to-treat and per-protocol analysis: A systematic review and meta-analysis
    Yoon Suk Lee
    Jong-Chan Lee
    Se Yeol Yang
    Jaihwan Kim
    Jin-Hyeok Hwang
    [J]. Scientific Reports, 9
  • [9] Neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer according to intention-to-treat and per-protocol analysis: A systematic review and meta-analysis
    Lee, Yoon Suk
    Lee, Jong-Chan
    Yang, Se Yeol
    Kim, Jaihwan
    Hwang, Jin-Hyeok
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [10] Inclusion of patients in clinical trial analysis: the intention-to-treat principle
    Heritier, SR
    Gebski, VJ
    Keech, AC
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2003, 179 (08) : 438 - 440
12345